This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Race Oncology Strategy Update Shareholder Q&A
Race Oncology CEO and MD Damian Clarke-Bruce and Chief Medical Officer Dr Michelle Rashford talked shareholders through Race’s refreshed corporate strategy and answered their questions during a webinar last week. Watch the full webinar here.